Summit Therapeutics SMMT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.24M+7.2% | $16.37M+0.6% | $4.87M-60.5% | $4.27M-72.8% | $7.68M+83.3% | ||
| $492.22M+229% | $488.18M+58.8% | $0-100% | $0-100% | $149.79M+57.0% | ||
| $316K-0.6% | $316K-2.8% | $321K-0.6% | $319K-0.3% | $318K+0.3% | ||
| $17.55M+92.5% | $6.54M-41.0% | $7.59M+215% | $11.05M+438% | $9.12M+71.3% | ||
| $616.6M+66.3% | $720.3M+70.0% | $246.47M-49.7% | $309.24M-5.9% | $370.75M+127% | ||
| $1.66M+155% | $1.06M+317% | $810K+206% | $690K+209% | $652K+260% | ||
| $19.4M+205% | $20.62M+189% | $5.42M-32.0% | $5.55M-36.3% | $6.35M-32.2% | ||
| $1.97M+2.2% | $2M+7.3% | $2M+0.4% | $2.04M+8.5% | $1.92M+2.6% | ||
| $8.23M+98.6% | $7.21M+183% | $7.03M+278% | $6.52M+247% | $4.15M+121% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $647.86M+68.8% | $751.18M+72.5% | $261.73M-48.0% | $324.04M-5.2% | $383.82M+117% | ||
| $27.55M+452% | $20.29M+338% | $22.25M+584% | $22.98M+588% | $4.99M-21.6% | ||
| $7.07M+60.9% | $14.93M+24.6% | $10.97M+37.7% | $6.59M+35.2% | $4.4M-27.1% | ||
| $3.18M-10.3% | $3.39M-10.0% | $2.72M-28.3% | $3.12M-15.5% | $3.54M-4.2% | ||
| $83.27M+139% | $72.99M+74.9% | $64.93M+10.0% | $60.33M-57.0% | $34.88M+48.8% | ||
| $16.86M+480% | $17.5M+407% | $2.71M-35.6% | $2.44M-51.5% | $2.91M-50.1% | ||
| —— | $20.89M+189% | —— | —— | —— | ||
| $1.8M+5.3% | $1.83M+12.4% | $1.83M+6.6% | $1.84M+15.2% | $1.71M-48.4% | ||
| $101.92M+158% | $92.32M+97.2% | $69.47M+7.0% | $64.6M-56.0% | $39.49M-70.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 1B0.0% | 1B+13,457% | 1B0.0% | 1B0.0% | 1B0.0% | ||
| $3.02B+87.0% | $2.95B+84.4% | $2.26B+42.6% | $2.1B+63.0% | $1.62B+50.2% | ||
| -$2.48B-94.4% | -$2.29B-88.9% | -$2.07B-79.9% | -$1.84B-68.0% | -$1.28B-23.2% | ||
| -$2.63M-2.7% | -$2.54M-11.2% | -$2.71M-17.4% | -$2.75M-10.1% | -$2.56M-4.7% | ||
| $545.93M+58.5% | $658.86M+69.5% | $192.26M-56.1% | $259.44M+33.0% | $344.33M+679% | ||
| $647.86M+68.8% | $751.18M+72.5% | $261.73M-48.0% | $324.04M-5.2% | $383.82M+117% | ||
| $8.23M+98.6% | $7.21M+183% | $7.03M+278% | $6.52M+247% | $4.15M+121% | ||
| $19.4M+205% | $20.62M+189% | $5.42M-32.0% | $5.55M-36.3% | $6.35M-32.2% | ||
| $19.4M+205% | $20.62M+189% | $5.42M-32.0% | $5.55M-36.3% | $6.35M-32.2% | ||
| $8.23M+98.6% | $7.21M+183% | $7.03M+278% | $6.52M+247% | $4.15M+121% | ||
| $492.22M+229% | $488.18M+58.8% | $0-100% | $0-100% | $149.79M+57.0% | ||
| $19.4M+205% | $20.62M+189% | $5.42M-32.0% | $5.55M-36.3% | $6.35M-32.2% | ||
| $8.23M+98.6% | $7.21M+183% | $7.03M+278% | $6.52M+247% | $4.15M+121% | ||
| $7.07M+60.9% | $14.93M+24.6% | $10.97M+37.7% | $6.59M+35.2% | $4.4M-27.1% | ||
| $44.32M+109% | $32.1M+64.2% | $27.04M+46.4% | $26.15M+110% | $21.19M+224% | ||
| $44.32M+109% | $32.1M+64.2% | $27.04M+46.4% | $26.15M+110% | $21.19M+224% | ||
| $7.07M+60.9% | $14.93M+24.6% | $10.97M+37.7% | $6.59M+35.2% | $4.4M-27.1% | ||
| $1.15M+51.3% | $2.28M+27.0% | $1.96M+90.5% | $1.49M+84.2% | $759K-3.7% | ||
| $20.04M+211% | $20.89M+189% | $5.43M-32.1% | $5.55M-36.2% | $6.45M-94.1% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 776M+4.6% | 775.4M+5.1% | 744.4M+1.0% | 742.8M+2.6% | 741.6M+5.6% | ||
| 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $7.76M+4.6% | $7.75M+5.1% | $7.44M+1.0% | $7.43M+2.6% | $7.42M+5.6% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $0— | $172K+72.0% | $0-100% | $0— | $0-100% | ||
| $4K-87.9% | $0— | $0— | $0-100% | $33K— | ||
| 0-100% | 0-100% | 0-100% | 0-100% | 1M-79.1% | ||
| $42.45M+128% | $31.5M+80.6% | $24.59M+157% | $24.58M+292% | $18.63M+207% | ||
| $4K-87.9% | $0— | $0— | $0-100% | $33K— | ||
| $0— | $172K+72.0% | $0-100% | $0— | $0-100% | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $1.05M-79.1% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $1B0.0% | $1B0.0% | $1B0.0% | $1B0.0% | $1B0.0% | ||
| $776.02M+4.6% | $775.37M+5.1% | $744.44M+1.0% | $742.81M+2.6% | $741.61M+5.6% | ||
| $776.02M+4.6% | $775.37M+5.1% | $744.44M+1.0% | $742.81M+2.6% | $741.61M+5.6% | ||
| $590.5M+67.0% | $696.91M+76.0% | $233.68M-40.5% | $293.61M-1.2% | $353.66M+271% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $590.49M+67.0% | $697.08M+76.0% | $233.68M-40.6% | $293.61M-1.2% | $353.63M+271% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $12.32M+89.8% | $4M-52.1% | $5.2M+598% | $8.16M+1,538% | $6.49M+49.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Summit Therapeutics's total assets?
- Summit Therapeutics (SMMT) holds $647.9M in total assets, up 68.8% year over year.
- How much debt does Summit Therapeutics have?
- Summit Therapeutics carries $20.0M in total debt against $545.9M of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Summit Therapeutics have?
- Summit Therapeutics holds $8.2M in cash and equivalents.
- Can Summit Therapeutics cover its short-term obligations?
- Its current ratio is 7.41 — current assets exceed current liabilities.
- Where does Summit Therapeutics's balance sheet data come from?
- Every line is extracted from Summit Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.